Biotech News
Helicore Biopharma Launches from Stealth Mode with $65M Series A Round
Helicore Biopharma, a company focused on developing novel treatments for obesity and related conditions, has announced the completion of a $65 million Series A financing round. The financing was co-led by founding investor Versant Ventures and OrbiMed, with additional participation
29 January 2025
Stay ahead of trends and best practices
